VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds

Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
You are here: IndiaNotes >> Market Insights - 14 September 2016 >> Is Pharma sector a safe haven in the falling market? - Market Insights Newsletter
14 | September | 2016 To view mail in browser, please click here Follow us on LinkedIn - Market Insights...take informed decisions
Research your Stock   |    Technical Calls   |    Live Market Action   |    Archives   |    Join Xchange

Welcome to Market Insights.

In this edition, we have Dynamic Levels commenting on whether the pharma sector could be a safe haven in the falling market. We also have, HDFC Securities recommending Nahar Industrial for the next 2-3 quarters, and Profit Track foreseeing Talbros Engineering as a potential multi-bagger in the auto ancillary sector. Lastly, we have SMC recommending UPL and Himatsingka Seide on fundamental grounds, and Andhra Bank and GAIL on technical grounds.

If you like us, please rate us on Facebook.

Talbros Engineering: A multi-bagger in the offing in auto ancillary sector

According to Profit Track, the stock has made rounding-bottom formation on chart. It is looking highly attractive at current level for investment. It is trading at PE ratio of 15. Moreover, the Company has paid 60% dividend for FY15. Hence, they believe that Talbros Engineering holds the potential to be a MULTIBAGGER stock in auto ancillary sector.

Click here to read the research report by Profit Track

Fundamental picks: These stocks have an upside of 26% & 22% respectively
According to SMC, UPL has strong fundamentals and robust outlook owing to its strong focus on brand building and customer reach. Similarly, Himatsingka Seide is enhancing its branded revenue streams. Thus, SMC find the two scrips ideal for a tenure of 8-10 months. SMC are also sharing with us the targets for both the scrips.

Is Pharma sector a safe haven in the falling market?
According to Dynamic Levels, the Pharma sector has made higher highs and lower lows in a period of one year owing to various factors at play. The Indian pharmaceuticals industry is expected to account for about 3.1-3.6 per cent of the global pharma industry by value and currently accounts for 10 per cent by volume, by the year 2016.

Running IPOs

Larsen Toubro Technology Services IPO


Technical Calls: Buy Andhra Bank and GAIL
According to SMC, GAIL managed to sustain on higher note despite the weakness in the market last week, which is bullish sign. Similarly, Andhra Bank has formed inverted head and shoulder formation on daily charts, which is also bullish in nature. Thus, SMC are recommending investors to buy both the scrips. They are also sharing with us the stop-losses and targets for both the scrips.

Pick of the Week: Buy Nahar Industrial at CMP & average at band of Rs 88-Rs95
According to HDFC Securities, the current valuations of Nahar Industrial look attractive on various parameters - 4.0xFY18 EPS, 0.53xFY18 P/BV, 0.20x FY18 Mcap to sales, 3.5xFY18 EV/EBITDA. They are expecting Nahar Industrial to do well in the coming years, and are hence recommending the scrip for the next 2-3 quarters.

Featured Equity Call for today by Way2Capital
Get day to day calls and stock tips with our Technical Newsletter section - Follow this page on LinkedIn here

Ask An Expert: Solutions to your queries just an e-mail away's Ask an Expert section has been very popular among our audience and readers. Our experts on board are known for giving prompt and convincing solutions to queries sent by our readers.

Many of our readers have received convincing solutions to their queries. Why not be one of them?

If you would like to contribute your content, get in touch with us at [email protected]
Do write in at
[email protected] and give us your feedback!

Advertise with us  |   Write for us   |   Blog on Xchange  |   Archives  |   Feedback
Privacy Policy